SunWay Biotech Co., LTD. (TPEX:1271)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
61.10
+0.30 (0.49%)
At close: Dec 5, 2025
-28.75%
Market Cap 3.69B
Revenue (ttm) 951.52M
Net Income (ttm) 84.86M
Shares Out 60.39M
EPS (ttm) 1.40
PE Ratio 43.64
Forward PE n/a
Dividend 1.33 (2.19%)
Ex-Dividend Date Jul 16, 2025
Volume 18,897
Average Volume 31,777
Open 61.90
Previous Close 60.80
Day's Range 60.70 - 61.90
52-Week Range 48.60 - 95.70
Beta -0.11
RSI 39.65
Earnings Date Nov 13, 2025

About SunWay Biotech Co., LTD.

SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan. [Read more]

Industry Packaged Foods
Founded 2007
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 1271
Full Company Profile

Financial Performance

In 2024, SunWay Biotech Co., LTD.'s revenue was 970.18 million, an increase of 69.88% compared to the previous year's 571.11 million. Earnings were 118.57 million, an increase of 157.26%.

Financial Statements

News

There is no news available yet.